Unbound MEDLINE

Substance P and vasoactive intestinal peptide levels in middle ear effusions of children.

Abstract

CONCLUSION
This is the first report demonstrating high levels of substance P (SP) that inversely correlate with vasoactive intestinal peptide (VIP) levels in middle ear effusions (MEEs) of patients with otitis media with effusion (OME). Increased SP and decreased VIP levels might play a role in the pathogenesis of chronic OME.
OBJECTIVE
The etiology of OME is multifactorial, and neurogenic inflammation may play a significant role. SP and VIP levels were not evaluated previously in MEEs of children with OME.
METHODS
Fifty patients aged 2-12 years (mean age 5.24 ± 2.64) were included in the study. MEEs were classified as mucoid or serous based on the gross appearance. SP and VIP levels were determined using ELISA.
RESULTS
High levels of SP were detected in MEEs. In addition SP levels were significantly higher in serous samples (2910.55 ± 307.96 vs 2218.55 ± 262.30 pg/ml). There were also age-dependent changes, such that SP levels were significantly higher in children aged 2-3 years compared with those who were 4-5 and 6-12 years old. VIP levels were undetectable in 30% of patients and the mean level of VIP was 50.91 ± 16.01 pg/ml in serous middle ear effusions and 54.86 ± 15.91 pg/ml in mucoid MEEs.

Links

  • Publisher Full Text
  • Authors

    Eyigor H, Osma U, Yilmaz MD, Eyigor M, Gultekin M, Erin N

    Institution

    Department of ENT Head and Neck Surgery, Antalya Education and Research Hospital, Turkey. hulinar@yahoo.com

    Source

    Acta oto-laryngologica 132:10 2012 Oct pg 1036-41

    MeSH

    Age Factors
    Biological Markers
    Child
    Child, Preschool
    Chronic Disease
    Cohort Studies
    Disease Progression
    Female
    Humans
    Male
    Otitis Media with Effusion
    Prognosis
    Prospective Studies
    Recurrence
    Sensitivity and Specificity
    Severity of Illness Index
    Sex Factors
    Statistics, Nonparametric
    Substance P
    Vasoactive Intestinal Peptide

    Pub Type(s)

    Comparative Study
    Journal Article

    Language

    eng

    PubMed ID

    22691066